Shandong Sihuan Pharmaceutical Co., Ltd., established in 2004, is a technology-based company engaged in the research, development, production, and sales of pharmaceutical raw materials.

The company's R&D center is located in the Overseas Student Pioneer Park of Jinan High-tech Zone, equipped with comprehensive testing facilities including 21 high-performance liquid chromatographs, two gas chromatographs, liquid chromatography-mass spectrometry systems, evaporative light scattering detectors, UV-visible spectrophotometers, freeze dryers, and other advanced instruments. The company boasts several senior experts with international research backgrounds and standards, possessing comprehensive capabilities from laboratory research and pilot-scale amplification to industrial production. Currently, the company employs 2 PhDs and over 20 master's degree holders, with scientific and technical personnel accounting for more than 30% of the workforce. The active pharmaceutical ingredient (API) production base is situated in Shandong Pingyuan Economic Development Zone, covering an area of over 40 acres. The GMP pharmaceutical manufacturing plant is located in the Dezhou Development Zone of Shandong, spanning more than 160 acres, and features high-standard modern workshops, administrative and experimental buildings, testing facilities, employee dormitories, canteens, and living areas.

The company's main products include Cefmenoxime Hydrochloride, Cefotiam Hydrochloride, Cefteram Pivoxil, Ceftizoxime, Cefcapene Pivoxil, Cefazedone Acid, Cefodizime Acid, Cefapirin Acid, Cefcapene Acid, Sodium Creatine Phosphate, α-Sulfophenylacetic Acid, Nafcillin Acid, Benzathine Cefapirin, Benzoic Acid Argelin, Trelagliptin Succinate, Newlistat, LCZ696, 4-Hydroxypyridine, 6-Chloro-3-methyluracil, among others.

With strong R&D capabilities, a high-quality product portfolio, a well-established production management system, and a good reputation, the company has laid a solid foundation for successful collaboration with pharmaceutical manufacturers. It has established strategic partnerships with several renowned domestic pharmaceutical companies, engaging in multi-level cooperation from research and development to production. We continue to extensively collaborate with long-standing partners while also exploring new areas of cooperation and building relationships with new partners. We sincerely hope to join hands with peers in the pharmaceutical industry to make greater contributions to the development of China's pharmaceutical sector.